BioCity was founded in December 2017. It is a pioneering pharmaceutical company established by local business owners with extensive knowledge of the Chinese pharmaceutical market and young scientists who have returned to China, leveraging the world's leading open drug innovation platform. The company is dedicated to discovering, developing, and commercializing new or highly distinct treatment candidates (without modality restrictions) for diseases with substantial unmet medical needs, particularly focusing on cancers and Nephropathy.
Biocity Biopharma
Headquarters
People's Republic of China